PRCT - Company ID 0001588978
The table below shows PROCEPT BioRobotics Corp's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$48.98M | -$99.21M | -$108.00M | -$80.38M | -$57.33M | -$48.34M |
| Capital expenditure | $9.36M | $4.41M | $25.21M | $2.65M | $592.00K | $233.00K |
| Investing cash flow | -$9.36M | -$4.41M | -$25.21M | -$2.65M | -$592.00K | -$233.00K |
| Dividends paid | - | - | - | - |
PROCEPT BioRobotics Corp reported operating cash flow of -$48.98M for fiscal year 2025. That is up 50.6% from -$99.21M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow declined from -$48.34M (FY 2020) to -$48.98M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $11.19M | $180.13M | $167.79M | $3.61M | $262.12M | $106.77M |